Alex Titomirov, Andrew Whiteley, Peter Staple | GenomeWeb

InforMax of Bethesda, Md., has found a replacement for founder and former CEO Alex Titomirov, who announced his plans to step down in October. Andrew Whiteley, previously vice president of bioinformatics at Amersham Biosciences, will succeed Titomirov as chairman, CEO, and president. Titomirov also resigned from the company’s board.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.